ONCOLYTICS BIOTECH INC.
Patent Owner
Stats
- 63 US PATENTS IN FORCE
- 2 US APPLICATIONS PENDING
- Apr 04, 2017 most recent publication
Details
- 63 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 826 Total Citation Count
- Aug 13, 1997 Earliest Filing
- 24 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2012/0273,424 METHODS OF PURIFYING VIRUSES USING GEL PERMEATION CHROMATOGRAPHYApr 27, 12Nov 01, 12[C09K, C12R, C12N, B01D]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9365823 Virus clearance of neoplastic cells from mixed cellular compositionsMay 28, 13Jun 14, 16[A61K, C12N]
8658158 Sensitization of chemotherapeutic agent resistant neoplastic cells with a virusSep 24, 12Feb 25, 14[A61K, C12N]
8609331 Use of ribozymes in the detection of adventitious agentsSep 27, 12Dec 17, 13[C07H, C12Q, A01N, C12P]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2013/0243,732 ABROGATING PROINFLAMMATORY CYTOKINE PRODUCTION DURING ONCOLYTIC REOVIRUS THERAPYAbandonedMay 21, 13Sep 19, 13[A61K]
2011/0243,890 Sensitization of Chemotherapeutic Agent Resistant Neoplastic Cells With a VirusAbandonedMay 17, 11Oct 06, 11[A61K, C12N, A61P]
2011/0086,005 MODULATING INTERSTITIAL PRESSURE AND ONCOLYTIC VIRAL DELIVERY AND DISTRIBUTIONAbandonedMay 27, 09Apr 14, 11[A61K, A61P]
2011/0053,249 Adenoviruses Mutated In The VA Genes For Cancer TreatmentAbandonedMay 27, 10Mar 03, 11[C12N]
2009/0202,489 ADENOVIRUSES MUTATED IN THE VA GENES FOR CANCER TREATMENTAbandonedMay 31, 07Aug 13, 09[A61K, C12N, A61P]
2008/0292,594 MUTANT REOVIRUSES AND METHODS OF MAKING AND USINGAbandonedMay 21, 08Nov 27, 08[A61K, C12N, A61P, C07K]
2008/0108,052 Use of Ribozymes in the Detection of Adventitious AgentsAbandonedMar 27, 07May 08, 08[C12Q]
2008/0081,032 Method for reducing pain using oncolytic virusesAbandonedJun 01, 07Apr 03, 08[A61K, A61P]
2008/0038,822 Virus clearance of neoplastic cells from mixed cellular compositionsAbandonedMay 30, 07Feb 14, 08[C12N]
2008/0026,048 Reovirus for the treatment of cellular proliferative disordersAbandonedMay 30, 07Jan 31, 08[A61K]
2008/0014,577 Oncolytic viruses as phenotyping agents for neoplasmsAbandonedMay 30, 07Jan 17, 08[C12Q]
2007/0190,032 Use of Local Immune Suppression to Enhance Oncolytic Viral TherapyAbandonedFeb 09, 07Aug 16, 07[A61K, A61N]
2007/0071,723 In Vivo Enhancement of Immune System Recognition of Neoplasms Following Treatment with an Oncolytic Virus or Gene Therapy VectorAbandonedAug 30, 06Mar 29, 07[A61K]
2005/0214,266 Combination of transplantation and oncolytic virus treatmentAbandonedMar 10, 05Sep 29, 05[A61K, C12N]
2005/0026,289 Virus clearance of neoplastic cells from mixed cellular compositionsAbandonedAug 31, 04Feb 03, 05[A61K, C12Q, C12N]
2005/0019,308 Oncolytic viruses for the treatment of neoplasms having activated PP2A or RacAbandonedJul 06, 04Jan 27, 05[A61K]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.